DRG will exhibit again at MEDLAB ME 2022 in Dubai!
It's an honor and privilege to show you our fully automated analyzer DRG:HYBRiD-XL® and how DRG can help to simplify customer´s work in diagnostic labs.
Recently we have launched few more new assays to our list such as Calprotectin and Pancreatic Elastase - Gastrointestinal disease for easy, clean and fast handling of stool sample!
In addition to the above we will highlight our new assay for the detection of AMH (Anti-Mullerian Hormone).
For the MEDLAB ME we would also like to reveal the secret that we are working on a new product group on our DRG:HYBRiD-XL®: Antibiotic TDMs which is going to be fully automated from sample to result. This will be UNIQUE WORLDWIDE: The Quantification of Antibiotics without LC-MS! As mentioned, the first 3 assays are fully automated on DRG:HYBRiD-XL® and will be launched soon: Ceftazidime, Linezolid and Ciprofloxacin.
Furthermore, to our fully automated analyzer DRG:HYBRiD-XL® we are proud to announce a new member at DRG: DxDATATM Automated Chemiluminescent lmmunoassay Analyzing System! FAST, EASY and COST EFFECTIVE!
This will come with plenty of interesting assay groups: Covid-19 Products, Cytokine Storm, TBI (Traumatic Brain lnjury), Cardiovascular & Cerebrovascular Disease, Diabetes, Maternal & Child Care and many more.
In addition to the presentation of our instruments and associated assays, DRG is also proud to highlight our NEW ELISAs like SARS-CoV-2 (RBD) Antibody, UNIQUE Estriol total, AMH (newly developed and produced at DRG´s German facility!) and several more kits.